Clinical Trial of Pulmonary Cryptococcosis in China

NCT02503449 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 260

Last updated 2015-07-21

No results posted yet for this study

Summary

The purpose of the study:1.Improve the understanding of the risk factors of pulmonary cryptococcosis;2.Improve the awareness of pulmonary cryptococcosis clinical and imaging manifestations;3.Grasp pulmonary cryptococcosis patients of clinical and imaging manifestations in different conditions;4.Learn about antibacterial activity of antifungal drugs for cryptococcosis in China.

Conditions

  • Cryptococcosis

Sponsors & Collaborators

  • Chinese PLA General Hospital

    collaborator OTHER
  • Beijing Chao Yang Hospital

    collaborator OTHER
  • Ministry of Health, China

    collaborator OTHER_GOV
  • Peking University Third Hospital

    collaborator OTHER
  • Tianjin Medical University General Hospital

    collaborator OTHER
  • First Hospital of China Medical University

    collaborator OTHER
  • Shengjing Hospital

    collaborator OTHER
  • Second Hospital of Jilin University

    collaborator OTHER
  • Shandong Provincial Hospital

    collaborator OTHER_GOV
  • Huadong Hospital

    collaborator OTHER
  • Nanjing PLA General Hospital

    collaborator OTHER
  • Fuzhou General Hospital

    collaborator OTHER
  • Guangzhou Institute of Respiratory Disease

    collaborator OTHER
  • Wuhan TongJi Hospital

    collaborator OTHER
  • Xi'an Jiaotong University

    collaborator OTHER
  • Guizhou Provincial People's Hospital

    collaborator OTHER
  • Shenyang Military General Hospital

    collaborator UNKNOWN
  • The Second Hospital of Hebei Medical University

    collaborator OTHER
  • Xiangya Hospital of Central South University

    collaborator OTHER
  • Fujian Provincial Hospital

    collaborator OTHER
  • Fuzhou Pulmonary Hospital of Fujian

    collaborator OTHER
  • Southwest Hospital, China

    collaborator OTHER
  • First Affiliated Hospital of Zhejiang University

    collaborator OTHER
  • Wenzhou Medical University

    collaborator OTHER
  • Shanghai Zhongshan Hospital

    collaborator OTHER
  • The First Affiliated Hospital of Nanchang University

    collaborator OTHER
  • Longyan City First Hospital

    collaborator OTHER
  • Zhixin Liang

    lead OTHER

Principal Investigators

  • Zhixin Liang, Doctor · Chinese PLA General Hospital

  • Zhen Wang · Beijing Chao Yang Hospital

  • Yanming Li · Ministry of Health, China

  • Lina Sun · Peking University Third Hospital

  • Jie Cao · Tianjin Medical University General Hospital

  • Yunzhuo Chu · First Hospital of China Medical University

  • Zhijie Zhang · Shengjing Hospital

  • Yufen Jin · Second Hospital of Jilin University

  • Xiaobin Ma · Shandong Provincial Hospital

  • Yanping Zhu · Huadong Hospital

  • Xin Su · Nanjing PLA General Hospital

  • Guoxiang Lai · Fuzhou General Hospital

  • Feng Ye · Guangzhou Institute of Respiratory Disease

  • Shengdao Xiong · Wuhan TongJi Hospital

  • Lan Yang · Xi'an Jiaotong University

  • Hong Yu · Guizhou Provincial People's Hospital

  • wencheng Xue · Shenyang Military General Hospital

  • Yadong Yuan · The Second Hospital of Hebei Medical University

  • Chengping Hu · Xiangya Hospital of Central South University

  • Baosong Xie · Fujian Provincial Hospital

  • Xiaohong Chen · Fuzhou Pulmonary Hospital of Fujian

  • Xiangdong Zhou · Southwest Hospital, China

  • Wenjiang Ma · First Affiliated Hospital of Zhejiang University

  • Yuping Li · Wenzhou Medical University

  • Hongni Jiang · Shanghai Zhongshan Hospital

  • Wei Bai · The First Affiliated Hospital of Nanchang University

  • Sucheng Zhong · Longyan City First Hospital

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-12-31
Primary Completion
2016-12-31
Completion
2017-12-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02503449 on ClinicalTrials.gov